Arginase 1 and arginase 2 variations associate with asthma, asthma severity and β2 agonist and steroid response

Rationale Arginase probably plays an important role in asthma development, severity and progression. Polymorphisms in arginase 1 and arginase 2 genes have been associated with childhood asthma and FEV1 reversibility to β2 agonists. Objectives We investigated the association between arginase 1 and arginase 2 polymorphisms and adult asthma, asthma severity and treatment response in a longitudinal cohort of 200 asthma patients. Methods Patients were studied during 1962–1975 and reexamined during 1990–1999, together with their families. Longitudinal data on lung function and treatment were extracted from medical records. Associations between haplotype-tagging polymorphisms in arginase 1 (n=3) and arginase 2 (n=8) and asthma, asthma severity, acute response to bronchodilators and chronic response to inhaled corticosteroids were analyzed. Measurements and main results Two polymorphisms in arginase 2 (rs17249437 and rs3742879) were associated with asthma and with more severe airway obstruction. Increased airway hyperresponsiveness and lower β2 agonist reversibility, but not anticholinergic reversibility, were associated with both arginase 1 and arginase 2. Inhaled corticosteroids slowed down the annual FEV1 decline, which was significantly less effective in homozygote carriers of the C-allele of the arginase 1 polymorphism, rs2781667. Conclusion We show that previously reported associations between arginase polymorphisms and childhood asthma are also present in adult asthma and the previously found associations with lower reversibility are specific for β2 agonists. Furthermore, we identified associations of arginase 1 and arginase 2 genes with asthma severity, as reflected by a lower lung function, more severe airway hyperresponsiveness, and less long-term response to inhaled corticosteroids. Studies on the functionality of the polymorphisms are warranted to further unravel the complex mechanisms underlying these observations.

[1]  P. Marsden,et al.  Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[2]  F. Gilliland,et al.  Roles of arginase variants, atopy, and ozone in childhood asthma. , 2009, The Journal of allergy and clinical immunology.

[3]  H. Meurs,et al.  l-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction , 2009, European Respiratory Journal.

[4]  H. Meurs,et al.  AIRWAY HYPERRESPONSIVENESS IN A GUINEA PIG MODEL OF CHRONIC ALLERGIC ASTHMA , 2009 .

[5]  A. Holian,et al.  Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice. , 2009, American journal of respiratory cell and molecular biology.

[6]  Y. Bossé,et al.  Airway wall remodeling in asthma: From the epithelial layer to the adventitia , 2008, Current allergy and asthma reports.

[7]  E. Bleecker,et al.  ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. , 2008, American journal of respiratory and critical care medicine.

[8]  W. Busse,et al.  Alterations of the arginine metabolome in asthma. , 2008, American journal of respiratory and critical care medicine.

[9]  J. Boucher,et al.  Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. , 2008, American journal of respiratory and critical care medicine.

[10]  A. Linderholm,et al.  Arginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: sources and consequences. , 2008, Toxicology and applied pharmacology.

[11]  H. Meurs,et al.  Arginase and pulmonary diseases , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

[12]  D. Voehringer,et al.  Disease-specific gene expression profiling in multiple models of lung disease. , 2008, American journal of respiratory and critical care medicine.

[13]  W. Seeger,et al.  Functional role and species-specific contribution of arginases in pulmonary fibrosis. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[14]  Da‐hong Wang,et al.  Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[15]  Gang Wei,et al.  Polyamine‐mediated regulation of protein acetylation in murine skin and tumors , 2007, Molecular carcinogenesis.

[16]  Matthew W. Foster,et al.  Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2 , 2007, Cell.

[17]  P. Thompson,et al.  Inhibition of Arginase I Activity by RNA Interference Attenuates IL-13-Induced Airways Hyperresponsiveness1 , 2006, The Journal of Immunology.

[18]  N. Sakata,et al.  Effects of inducible nitric oxide synthase inhibitors on asthma depending on administration schedule. , 2006, Free radical biology & medicine.

[19]  D. Postma,et al.  Estrogen receptor 1 polymorphisms are associated with airway hyperresponsiveness and lung function decline, particularly in female subjects with asthma. , 2006, The Journal of allergy and clinical immunology.

[20]  H. Meurs,et al.  Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma , 2006, Respiratory research.

[21]  E. Kistner,et al.  Genetic polymorphisms in arginase I and II and childhood asthma and atopy. , 2006, The Journal of allergy and clinical immunology.

[22]  J. A. Hendrickson,et al.  Arginase activity differs with allergen in the effector phase of ovalbumin- versus trimellitic anhydride-induced asthma. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  D. Postma,et al.  Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex , 2005, Thorax.

[24]  G. Visner,et al.  Pirfenidone Inhibits Lung Allograft Fibrosis through L‐Arginine–Arginase Pathway , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  Marieke A Tio,et al.  Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation , 2005, Respiratory research.

[26]  A. Bucht,et al.  Increased levels of hypoxia-sensitive proteins in allergic airway inflammation. , 2004, American journal of respiratory and critical care medicine.

[27]  S. Morris,et al.  Decreased arginine bioavailability and increased serum arginase activity in asthma. , 2004, American journal of respiratory and critical care medicine.

[28]  I. Adcock,et al.  Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. , 2004, The Journal of allergy and clinical immunology.

[29]  I. Adcock,et al.  Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.

[30]  H. Meurs,et al.  Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. , 2003, Trends in pharmacological sciences.

[31]  Qutayba Hamid,et al.  Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. , 2003, The Journal of clinical investigation.

[32]  C. Billington,et al.  Signaling and regulation of G protein-coupled receptors in airway smooth muscle , 2003, Respiratory research.

[33]  W. MacNee,et al.  Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[34]  I. Adcock,et al.  Expression and activity of histone deacetylases in human asthmatic airways. , 2002, American journal of respiratory and critical care medicine.

[35]  H. Meurs,et al.  Increased arginase activity underlies allergen‐induced deficiency of cNOS‐derived nitric oxide and airway hyperresponsiveness , 2002, British journal of pharmacology.

[36]  D. Postma,et al.  Major genes regulating total serum immunoglobulin E levels in families with asthma. , 2000, American journal of human genetics.

[37]  J. Boucher,et al.  Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity , 2000, British journal of pharmacology.

[38]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[39]  Guoyao Wu,et al.  Arginine metabolism: nitric oxide and beyond. , 1998, The Biochemical journal.

[40]  C. Piantadosi,et al.  Induction of arginase isoforms in the lung during hyperoxia. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[41]  D. Postma,et al.  Characterization of obstructive airway disease in family members of probands with asthma. An algorithm for the diagnosis of asthma. , 1998, American journal of respiratory and critical care medicine.

[42]  J. Zweier,et al.  Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Kurosawa,et al.  Elevated levels of peripheral‐blood, naturally occurring aliphatic polyamines in bronchial asthmatic patients with active symptoms , 1992, Allergy.